A clinical investigator from the University of Kansas School of Medicine, Patrick M. Moriarty, co-led a clinical trial testing a drug focusing on individuals who have inherited a condition subjecting them to high cholesterol irrespective of diet or lifestyle. The...
Lipoprotein(a) (Lp(a))
Category
PharmaWatch: Novartis Pays $150 Million to Pursue Transformational Cardiovascular Disease Therapy
As reported in West Globe Newswire, Novartis has announced its’ move into developing a targeted cardiovascular therapy by exercising an option to license the rights to develop and commercialize TQJ230, an investigational agent preciously known as AKCEA-APO(a)-LRx,...